gadobenate dimeglumine
gadobenate dimeglumine is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including MultiHance. Available dosage forms: powder, injection, solution.
Drug Details
- Generic Name
- gadobenate dimeglumine
- Brand Names
- MultiHance
- Application Number
- NDA021357
- Sponsor
- BRACCO IMAGING SPA
- NDC Codes
- 3
- Dosage Forms
- POWDER, INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- GADOBENATE DIMEGLUMINE
Indications and Usage
1 INDICATIONS AND USAGE magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults and pediatric patients (including term neonates), to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues (1.1) magnetic resonance angiography (MRA) to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease. (1.2) 1.1 Magnetic Resonance Imaging (MRI) of the Central Nervous System (CNS) MultiHance is indicated for intravenous use in magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults and pediatric patients (including term neonates), to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues. 1.2 Magnetic Resonance Angiography (MRA) of Renal and Aorto-ilio-femoral Vessels MultiHance is indicated for use in magnetic resonance angiography (MRA) to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease.